Phase I Trial of Intratumoral Administration of NIS Expressing Strain of Measles Virus in Unresectable or Recurrent Malignant Peripheral Nerve Sheath Tumor

Abstract

Study approved by Mayo IRB on April 18, 2016, and by USAMRMC/ORP/HRPO on May 6, 2016. All study staff completed IRB training. Dose volume charts have been developed to facilitate pharmacy orders. Study opened for enrollment on May 17, 2016. Study coordinators identified and assigned to the study by Mayo Clinic Cancer Center. One patient was identified as a possible study participant, but before enrollment she required hospitalization for pulmonary embolus. Due to treatment with anticoagulants, the patient was not eligible for participation. We are continuing study enrollment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2016
Accession Number
AD1020694

Entities

People

  • Dusica Babovic-vuksanovic

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Clinical Trials
  • Department Of Defense
  • Education
  • Electronic Mail
  • Gene Expression
  • Health Services
  • Information Operations
  • Neoplasms
  • Oncolytic Viruses
  • Patent Applications
  • Peripheral Nervous System
  • Pharmacies
  • Professional Development
  • Technology Transfer
  • Training
  • Viruses

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).